Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia

Treatment of chronic myeloid leukemia with BCR-ABL tyrosine kinase inhibitors requires full adherence in order to maximize the likelihood of achieving optimal responses, and to minimize healthcare costs. In this article, we review some of the methods available for assessing compliance, the main cons...

Descripción completa

Detalles Bibliográficos
Autores principales: de Almeida, Maria Helena, Fogliatto, Laura, Couto, Dulce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2014
Materias:
Review article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948667/
https://www.ncbi.nlm.nih.gov/pubmed/24624037
http://dx.doi.org/10.5581/1516-8484.20140014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948667/
https://www.ncbi.nlm.nih.gov/pubmed/24624037
http://dx.doi.org/10.5581/1516-8484.20140014

Ejemplares similares